Status:
COMPLETED
Specifying Interventions From the Sickle Cell Disease Implementation Consortium (SCDIC)
Lead Sponsor:
Washington University School of Medicine
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Anemia, Sickle Cell
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this study is to specify the interventions, implementation strategies and control conditions from the Sickle Cell Disease Implementation Consortium (SCDIC) using a mixed-methods approach t...
Detailed Description
The long-term goal of this line of research is to identify the most effective components of SCD interventions while also identifying effective implementation strategies informed by a systematic and ri...
Eligibility Criteria
Inclusion
- three representatives of each of the SDIC sites: the Principal Investigator, and two people nominated by the PI.
Exclusion
- none
Key Trial Info
Start Date :
August 26 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 30 2024
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT03380351
Start Date
August 26 2019
End Date
March 30 2024
Last Update
May 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University in St. Louis
St Louis, Missouri, United States, 63110